Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Ching Lin

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Histopathology|November 14, 2014
PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapyHong-Lin He, Ying-En Lee, Yow-Ling Shiue, et al.
Frontiers in Oncology|June 18, 2020
Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate CancerShih-Chang Wang, Wei-Chen Ting, Yun-Ching Chang, et al.
Oncotargets and Therapy|June 9, 2018
Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort studyYu-Ching Wei, Sheau-Fang Yang, Shih-Lun Chang, et al.
Oxidative Medicine and Cellular Longevity|March 7, 2018
36H: A Novel Potent Inhibitor for AntimelanogenesisLi-Ching Lin, Chung-Yi Chen, Chia-Hung Kuo, et al.
Surgical Oncology|March 16, 2007
p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapyLi-Ching Lin, Hao-Hsien Lee, Wei-Shou Hwang, et al.
Scientific Reports|April 26, 2025
The significance of the depth of invasion and tumor size in resected pathologic T4a gingivobuccal squamous cell carcinomaWei-Ju Hong, Li-Tsun Shieh, Ching-Yu Yen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 2, 2015
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapyYing-En Lee, Hong-Lin He, Yow-Ling Shiue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 8, 2014
Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapyYi-Ying Lee, Chien-Feng Li, Ching-Yih Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 2, 2013
Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinomaLi-Jung Ma, Sung-Wei Lee, Li-Ching Lin, et al.
American Journal of Translational Research|January 26, 2016
Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancerCheng-Yi Lin, Ching-Yih Lin, I-Wei Chang, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Histopathology|November 14, 2014
PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapyHong-Lin He, Ying-En Lee, Yow-Ling Shiue, et al.
Frontiers in Oncology|June 18, 2020
Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate CancerShih-Chang Wang, Wei-Chen Ting, Yun-Ching Chang, et al.
Oncotargets and Therapy|June 9, 2018
Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort studyYu-Ching Wei, Sheau-Fang Yang, Shih-Lun Chang, et al.
Oxidative Medicine and Cellular Longevity|March 7, 2018
36H: A Novel Potent Inhibitor for AntimelanogenesisLi-Ching Lin, Chung-Yi Chen, Chia-Hung Kuo, et al.
Surgical Oncology|March 16, 2007
p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapyLi-Ching Lin, Hao-Hsien Lee, Wei-Shou Hwang, et al.
Scientific Reports|April 26, 2025
The significance of the depth of invasion and tumor size in resected pathologic T4a gingivobuccal squamous cell carcinomaWei-Ju Hong, Li-Tsun Shieh, Ching-Yu Yen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 2, 2015
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapyYing-En Lee, Hong-Lin He, Yow-Ling Shiue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 8, 2014
Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapyYi-Ying Lee, Chien-Feng Li, Ching-Yih Lin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 2, 2013
Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinomaLi-Jung Ma, Sung-Wei Lee, Li-Ching Lin, et al.
American Journal of Translational Research|January 26, 2016
Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancerCheng-Yi Lin, Ching-Yih Lin, I-Wei Chang, et al.
Pageof 11